These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1646566)
1. Receptor function in heart failure. Bogaert MG; Fraeyman N Am J Med; 1991 May; 90(5B):10S-13S. PubMed ID: 1646566 [TBL] [Abstract][Full Text] [Related]
2. Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. Brodde OE; Zerkowski HR; Doetsch N; Motomura S; Khamssi M; Michel MC J Am Coll Cardiol; 1989 Aug; 14(2):323-31. PubMed ID: 2569001 [TBL] [Abstract][Full Text] [Related]
3. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure. Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446 [TBL] [Abstract][Full Text] [Related]
4. Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs. Fan TH; Liang CS; Kawashima S; Banerjee SP Eur J Pharmacol; 1987 Aug; 140(2):123-32. PubMed ID: 2822436 [TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha. Makino T; Hattori Y; Matsuda N; Onozuka H; Sakuma I; Kitabatake A J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614 [TBL] [Abstract][Full Text] [Related]
6. Mitigation of beta 1- and/or beta 2-adrenoceptor function in human heart failure. Michel MC; Maisel AS; Brodde OE Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):37S-42S. PubMed ID: 2176527 [TBL] [Abstract][Full Text] [Related]
7. Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure. Brodde OE; Hillemann S; Kunde K; Vogelsang M; Zerkowski HR J Heart Lung Transplant; 1992; 11(4 Pt 2):S164-74. PubMed ID: 1355362 [TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of the beta-adrenoceptor system in chronic heart failure: consequences for treatment with agonists, partial agonists or antagonists? Brodde OE Eur Heart J; 1991 Dec; 12 Suppl F():54-62. PubMed ID: 1687117 [TBL] [Abstract][Full Text] [Related]
9. Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure. Ruffolo RR; Kopia GA Am J Med; 1986 Feb; 80(2B):67-72. PubMed ID: 2868661 [TBL] [Abstract][Full Text] [Related]
10. [Beta-adrenergic receptors of the normal heart and in heart failure]. Krasnikov TL; Gabrusenko SA Usp Fiziol Nauk; 2000; 31(2):35-50. PubMed ID: 10822833 [TBL] [Abstract][Full Text] [Related]
11. The beta-adrenergic receptors. Wallukat G Herz; 2002 Nov; 27(7):683-90. PubMed ID: 12439640 [TBL] [Abstract][Full Text] [Related]
12. Distribution of myocardial beta-adrenoceptor subtypes and coupling to the adenylate cyclase in children with congenital heart disease and implications for treatment. Kozlik-Feldmann R; Kramer HH; Wicht H; Feldmann R; Netz H; Reinhardt D J Clin Pharmacol; 1993 Jul; 33(7):588-95. PubMed ID: 8396157 [TBL] [Abstract][Full Text] [Related]
13. Distinct down-regulation of cardiac beta 1- and beta 2-adrenoceptors in different human heart diseases. Steinfath M; Geertz B; Schmitz W; Scholz H; Haverich A; Breil I; Hanrath P; Reupcke C; Sigmund M; Lo HB Naunyn Schmiedebergs Arch Pharmacol; 1991 Feb; 343(2):217-20. PubMed ID: 1648674 [TBL] [Abstract][Full Text] [Related]
14. Drug- and disease-induced changes of human cardiac beta 1- and beta 2-adrenoceptors. Brodde OE; Zerkowski HR; Borst HG; Maier W; Michel MC Eur Heart J; 1989 Jun; 10 Suppl B():38-44. PubMed ID: 2553410 [TBL] [Abstract][Full Text] [Related]
15. [Adrenergic beta receptors and guanine nucleotide binding proteins (G-proteins) of the failing human heart]. Böhm M; Schwinger RH; Erdmann E Z Kardiol; 1992; 81 Suppl 4():23-31. PubMed ID: 1337808 [TBL] [Abstract][Full Text] [Related]
16. The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure. Khamssi M; Brodde OE J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S133-7. PubMed ID: 11527117 [TBL] [Abstract][Full Text] [Related]
17. Intrinsic sympathomimetic activity of beta-adrenoceptor antagonists: down-regulation of cardiac beta 1- and beta 2-adrenoceptors. Reithmann C; Wieland F; Jakobs KH; Werdan K Eur J Pharmacol; 1989 Nov; 170(3):243-55. PubMed ID: 2575997 [TBL] [Abstract][Full Text] [Related]
18. Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure. Sjaastad I; Schiander I; Sjetnan A; Qvigstad E; Bøkenes J; Sandnes D; Osnes JB; Sejersted OM; Skomedal T Acta Physiol Scand; 2003 Apr; 177(4):449-58. PubMed ID: 12648162 [TBL] [Abstract][Full Text] [Related]
19. Quantification of beta-adrenoceptors and beta-adrenoceptor kinase on protein and mRNA levels in heart failure. Böhm M; Lohse MJ Eur Heart J; 1994 Dec; 15 Suppl D():30-4. PubMed ID: 7713110 [TBL] [Abstract][Full Text] [Related]
20. Effects of beta-adrenergic blockade on papillary muscle function and the beta-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction. Warner AL; Bellah KL; Raya TE; Roeske WR; Goldman S Circulation; 1992 Nov; 86(5):1584-95. PubMed ID: 1330362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]